Search Results
351 items found for "cancer cell lines"
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
DIEGO, Dec. 7, 2021 /PRNewswire/ -- Neurocrine Biosciences (Nasdaq: NBIX) today announced positive top-line
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules) Among the top-ranked compounds, 59 fragments and 59 lead-like compounds were selected for experimental Of these, four fragment- and seven lead-like compounds were confirmed to bind to the allosteric site The results demonstrate that virtual screens of fragment- and lead-like chemical libraries have complementary
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Chemical libraries containing fragment- (1.6 million molecules) and lead-like (4.6 million molecules) Among the top-ranked compounds, 59 fragments and 59 lead-like compounds were selected for experimental Of these, four fragment- and seven lead-like compounds were confirmed to bind to the allosteric site The results demonstrate that virtual screens of fragment- and lead-like chemical libraries have complementary
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
GPCRs are present in a range of conformations, and the binding of a ligand, as well as interactions with signaling molecules like G proteins, can selectively stabilize specific conformations (Gether 2000). growth in the discovery of allosteric modulators for GPCRs which possess the capability to modulate and fine-tune The significance of spatio-temporal attributes in signaling is demonstrated in processes like neurotransmission different ligands inducing unique GPCR conformations that selectively activate specific cellular outcomes linked
- 📰 GPCR Weekly News, March 4 to 10, 2024
We are pleased to confirm the participation of a great lineup of speakers, namely Drs.
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors. To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better
- Episode 86 of the Dr. GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available!
📹Would you like to see the video? Subscribe to a Dr.
- Trainees, this is for you...
Would you like to develop your presentation skills? Give a talk or present a poster at the Dr.
- ShouTi Pharma has a brand new website
experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing
- Mark Schmeizl - Dr. GPCR Podcast
He is a pro at Matchmaking the top talent in the life sciences with the industry’s leading companies.
- 📰 GPCR Weekly News, October 2 to 8, 2023
silico identification of a biarylamine acting as agonist at human β3 adrenoceptors and exerting BRL37344-like Endothelin-B receptor probes GPCRs in Cardiology, Endocrinology, and Taste GPRASP1 loss-of-function links malformations by endothelial activating GPR4 signals GPCRs in Neuroscience Involvement of a silkworm D2-like
- Dr. Mark Connor - Dr. GPCR Podcast
Learn more about #GPCRs and life as an academic wearing different hats.
- Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias...
regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias and disrupts the fine-tuning
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
explored for treating central nervous system and neurologic disorders, particularly movement disorders like
- Domain Therapeutics Raises $42m Series A Financing
announced today the closing of a US $42m (€39m) series A financing round co-led by Panacea Venture, CTI Life
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties
- Crinetics Presents Clinical And Research Results At ENDO 2022
serum cortisol levels and 24-hour urine free cortisol excretion in the presence of sustained, disease-like
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
we investigate the conformational changes induced by the binding of a nanobody (Nb80) on the active-like transmembrane helix 6 and a close proximity of transmembrane (TM) helices 5 and 7, and favors the fully active-like ligand-binding sites, primarily involving residues around ICL2 and the intracellular end of TM3, TM5, TM6, as well
- Search for safer pain relief advances with new engineered compounds
Scientists at Scripps Research in Florida have created a collection of new pain-relieving compounds that, like
- California gold rush for Sosei Heptares
November 2021 "Cambridge’s Japanese-owned life sciences company Sosei Heptares has clinched a lucrative
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
Design Pharmaceuticals ’ platform is based on ultrahigh-throughput technologies that biomine drug-like
- Fusion protein strategies for cryo-EM study of G protein-coupled receptors
The fusion strategies explored here are likely applicable to cryo-EM interrogation of other GPCRs and
- G-protein-coupled receptors as therapeutic targets for glioblastoma
Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with
- 4GPCRnet - International Symposium
will take place in the heart of Leipzig, which offers a colorful mixture of culture and vivid social life
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
These sites cluster at nine distinct locations, and each can be found in many different proteins. specifically targeting these sites across GPCRs for allosteric modulation and help to identify the most likely
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences